2012
DOI: 10.1007/978-1-61779-854-2_8
|View full text |Cite
|
Sign up to set email alerts
|

Assessment of Gelatinases (MMP-2 and MMP-9) by Gelatin Zymography

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

7
254
0
9

Year Published

2015
2015
2024
2024

Publication Types

Select...
6
1
1

Relationship

0
8

Authors

Journals

citations
Cited by 313 publications
(280 citation statements)
references
References 32 publications
7
254
0
9
Order By: Relevance
“…Activity of MMP-2 was determined by zymography assay [19]. After treatment the culture medium was loaded on a SDS-polyacrylamide (10%) gel containing 1% gelatin.…”
Section: Western Blot Analysis Of Collagen and Mmp Expression And Zymmentioning
confidence: 99%
“…Activity of MMP-2 was determined by zymography assay [19]. After treatment the culture medium was loaded on a SDS-polyacrylamide (10%) gel containing 1% gelatin.…”
Section: Western Blot Analysis Of Collagen and Mmp Expression And Zymmentioning
confidence: 99%
“…The bulk hydrogels of photocrosslinked gelatin methacryloyl were used in drug delivery and tissue engineering applications for its biocompatibility (23). Gelatin also contains target cleavage sites for MMP-2, thereby appealing as a biodegradable structural material for microrobots (24). The present study also shows hydrogels as a useful material platform for microswimmers to carry concentrated therapeutics in their bulk volume.…”
Section: Introductionmentioning
confidence: 70%
“…Furthermore, most MMPs are secreted as zymogenes upon cytokine stimulation and require extracellular proteolytic activation. MMP-2 (gelatinase A, EC 3.4.24.24) and MMP-9 (gelatinase B, EC 3.4.24.35) have been extensively studied owing to their consistent association with tumor invasion and metastasis (Toth and Fridman, 2001;Verma and Hansch, 2007). In this way inhibition of expression, conversion and/or biological (enzymatic) function of these proteases may block angiogenesis both in vivo and in vitro (Kappert et al, 2009;Verma and Hansch, 2007).…”
Section: Resultsmentioning
confidence: 99%
“…It is noteworthy that 4-aryl-chromenes with methoxy substitution(s) at 4-position, have been identified as potent vascular disrupting agents (Cai et al, 2009;Kasibhatla et al, 2004). Vascular disrupting agents, which are a new class of potential anti-cancer drugs, disrupt preformed endothelial Lanes 1 and 8 represent the ConA (as positive control, note the relative induction of MMP-2 in response to ConA, at 5 lg/ml, compared to other lanes) and tetracycline (as negative control) effects on MMP activity, respectively (Toth and Fridman, 2001). Note the partial inhibition of MMP-2 (62-72 kDa) and complete suppression of MMP-9 (100 kDa), at 2 lg/ml of tetracycline (Kappert et al, 2009).…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation